摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-Methoxy-9-oxononanoate

中文名称
——
中文别名
——
英文名称
9-Methoxy-9-oxononanoate
英文别名
——
9-Methoxy-9-oxononanoate化学式
CAS
——
化学式
C10H17O4-
mdl
——
分子量
201.24
InChiKey
VVWPSAPZUZXYCM-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    66.4
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Improved Process for the Production of Derivatives of Saturated Carboxylic Acids
    摘要:
    一种生产羧酸及其衍生物的方法,包括以下步骤:(c)在催化剂的存在下,将不饱和脂肪酸衍生物与氧化剂反应,催化剂能够催化不饱和脂肪酸衍生物的双烯键氧化反应,从而得到邻二醇的中间产物;(d)在催化剂的存在下,将该中间化合物与氧气或含氧化合物反应,催化剂能够催化邻二醇的羟基氧化反应成为羧基,其特征在于步骤(a)和(b)都在无添加有机溶剂的情况下进行,并且步骤(b)中的水/二醇比小于1:1。
    公开号:
    US20080245995A1
点击查看最新优质反应信息

文献信息

  • Organic Compounds and their uses
    申请人:Britt Shawn D.
    公开号:US20100240638A1
    公开(公告)日:2010-09-23
    The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.
    本申请描述了公式(I)的大环化合物,具有NS3蛋白酶抑制活性,用于治疗丙型肝炎病毒感染。
  • ORALLY AVAILABLE VIRIDIOFUNGIN DERIVATIVE POSSESSING ANTI-HCV ACTIVITY
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:US20150210666A1
    公开(公告)日:2015-07-30
    An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
    本发明的目的是提供一种可口服的抗丙型肝炎病毒药物化合物。本发明涉及一种由式(1)所表示的化合物或其药学上可接受的盐。该化合物具有抗丙型肝炎病毒的活性,是一种有用的药物。
  • Orally available viridiofungin derivative possessing anti-HCV activity
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:US09266853B2
    公开(公告)日:2016-02-23
    An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
    本发明的目的是提供一种可口服的抗HCV药物。本发明涉及一种由式(1)表示的化合物或其药学上可接受的盐。该化合物具有抗HCV活性,可作为药物使用。
  • Improved Process for the Production of Derivatives of Saturated Carboxylic Acids
    申请人:Bastioli Catia
    公开号:US20080245995A1
    公开(公告)日:2008-10-09
    A process for the production of carboxylic acids and their derivatives comprising the steps of: (c) reacting a derivative of an unsaturated fatty acid with an oxidizing compound in the presence of a catalyst capable of catalysing the reaction of oxidation of the double olefinic bond of the derivative of the unsaturated fatty acid so as to obtain as intermediate product of reaction a vicinal diol; and (d) reacting said intermediate compound with oxygen, or a compound containing oxygen, in the presence of a catalyst capable of catalysing the reaction of oxidation of the hydroxyl groups of the vicinal diol to carboxylic groups, characterized in that both of the steps (a) and (b) are carried out in the absence of added organic solvent and in that the water/diol ratio in the reaction of step (b) is less than 1:1.
    一种生产羧酸及其衍生物的方法,包括以下步骤:(c)在催化剂的存在下,将不饱和脂肪酸衍生物与氧化剂反应,催化剂能够催化不饱和脂肪酸衍生物的双烯键氧化反应,从而得到邻二醇的中间产物;(d)在催化剂的存在下,将该中间化合物与氧气或含氧化合物反应,催化剂能够催化邻二醇的羟基氧化反应成为羧基,其特征在于步骤(a)和(b)都在无添加有机溶剂的情况下进行,并且步骤(b)中的水/二醇比小于1:1。
查看更多